Status:
COMPLETED
Effect of Exercise on Disease Activity and Cardiovascular Risk Factors in Patients With Ankylosing Spondylitis
Lead Sponsor:
Diakonhjemmet Hospital
Collaborating Sponsors:
University of Oslo
Conditions:
Ankylosing Spondyliti
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Background: Exercise is recommended as a cornerstone in the treatment of ankylosing spondylitis together with medication. Last years, increased risk of cardiovascular diseases in patient with inflamm...
Eligibility Criteria
Inclusion
- Diagnosis of ankylosing spondylitis, confirmed by a rheumatologist
- Age, 18-70 years
- Not using TNF-α medication or steady medication for ≥3 months
- Disease activity ≥2.1 on ankylosing spondylitis disease activity score defined as high disease activity
- Not participated in a structured cardiorespiratory or muscle strengthening exercise program during the last year (\>60 min once per week), including large amounts of brisk walking (\>120 min per week)
Exclusion
- Known cardiovascular disease
- Severe comorbidity which involves reduced exercise capacity
- Not able to participate in weekly exercises sessions in Oslo
- Pregnancy
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01436942
Start Date
September 1 2011
End Date
May 1 2012
Last Update
February 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diakonhjemmet Hospital
Oslo, Norway